Changes in the Lymphatic System on the MR Lymphangiography (MRL) In Patients with Liver Cirrhosis
Recruiting
18-100 years
All
Phase
1
30 participants needed
1 Location
Brief description of study
This is an observational
study that will compare the differences in lymphatic flow and anatomy of the central
lymphatic system on MRL in the liver cirrhosis patients with and without
ascites. In the second part of the study, MRL anatomical and flow changes in
the central lymphatic system of patients with liver cirrhosis will be compared
to normative data in healthy individuals.
In ascites group, the degree of anatomical and
lymphatic flow changes on MRL will be then correlated with volume of the
ascites.
Detailed description of study
Our group routinely
uses MR Lymphangiography (MRL) in a clinical setting to image the lymphatic
system in patients with plastic bronchitis, chylothorax and lymphangiomatosis ADDIN CSL_CITATION { "citationItems" : [ {
"id" : "ITEM-1", "itemData" : { "DOI" :
"10.1148/rg.2017170014", "ISSN" : "0271-5333",
"PMID" : "29019760", "abstract" : "The
lymphatic system, an important component of the circulatory system with
essential physiologic functions, can be affected by various disease processes.
There has been a delay in the development of effective imaging methods for the
lymphatic system due to its small size, which limits visualization as well as
introduction of contrast material. Traditionally, the lymphatic system has been
imaged by injecting contrast material or radiotracers into the feet or hands.
This is not sufficient for assessment of the central conducting lymphatics
(CCLs) (such as the thoracic duct or the cisterna chyli). Fluoroscopic
intranodal lymphangiography with injection of oil-based contrast material into
groin lymph nodes improves visualization of CCLs but is limited in practice
owing to the use of radiation and the potential risk for paradoxical
embolization in children with left-to-right shunt. Dynamic contrast
material-enhanced (DCE) magnetic resonance (MR) lymphangiography, which is
performed by injecting gadolinium-based contrast material into groin lymph
nodes, overcomes these limitations. T2-weighted imaging plays a complementary
role to DCE MR lymphangiography in the assessment of CCLs. DCE MR
lymphangiography demonstrates preserved integrity or any abnormality of the
CCLs (including blockage or leak). The technique has recently been used in
evaluating pulmonary lymphatic perfusion syndrome in children with plastic
bronchitis, neonatal lymphatic flow disorders, and nontraumatic chylothorax. It
is useful in identification of the source of chylous ascites and contributes to
understanding of the anatomy of lymphatic malformations. It is successfully
used for planning of embolization of aberrant lymphatic channels in a variety
of lymphatic flow disorders. This review discusses the anatomy and function of
the lymphatic system, the evolution of imaging of the lymphatic system, and DCE
MR lymphangiography technique and its applications in children. \u00a9RSNA,
2017.", "author" : [ { "dropping-particle" :
"", "family" : "Chavhan", "given" :
"Govind B.", "non-dropping-particle" : "",
"parse-names" : false, "suffix" : "" }, {
"dropping-particle" : "", "family" :
"Amaral", "given" : "Joao G.",
"non-dropping-particle" : "", "parse-names" :
false, "suffix" : "" }, { "dropping-particle" :
"", "family" : "Temple", "given" :
"Michael", "non-dropping-particle" : "",
"parse-names" : false, "suffix" : "" }, {
"dropping-particle" : "", "family" :
"Itkin", "given" : "Maxim",
"non-dropping-particle" : "", "parse-names" :
false, "suffix" : "" } ], "container-title" :
"RadioGraphics", "id" : "ITEM-1",
"issue" : "6", "issued" : {
"date-parts" : [ [ "2017" ] ] }, "page" :
"1775-1790", "title" : "MR Lymphangiography in
Children: Technique and Potential Applications", "type" :
"article-journal", "volume" : "37" },
"uris" : [
"http://www.mendeley.com/documents/?uuid=8fe51700-de03-44ba-a878-30fa7f534123"
] } ], "mendeley" : { "formattedCitation" : "(13)",
"plainTextFormattedCitation" : "(13)",
"previouslyFormattedCitation" : "(13)" },
"properties" : { },
"schema" :
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json"
}(13). This new technique allowed imaging and
physiological evaluation of the central lymphatic system that includes cisterna
chyli and the thoracic duct. MRL not only
allowed for understanding of the pathophysiology of these disorders, but also
provided an excellent tool in planning of the interventional procedure.
The goal of this
study is to compare the changes in the central lymphatic system in liver
cirrhosis patients with and without the ascites.
We believe that the application of MRL in patient with liver cirrhosis
will be an effective means to assess flow velocity and volume in the thoracic
duct. It can further provide valuable insight into the pathophysiology of
changes in the lymphatic flow in the central lymphatic system in patient with
liver cirrhosis and ascites. We hope that our study will shed light on
pathophysiology of the ascites in liver cirrhosis.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Healthy
-
Age: Between 18 Years - 100 Years
-
Gender: All
·
Participants
must be age 18 or older
·
Participants
have to be able to lie flat for at least one hour
·
Participants
must be able to understand English and be able to review and comprehend the
informed consent form independently or with the help of research staff
·
Participants
must sign the informed consent form
Normal participants:
·
Absence
of any signs or symptoms consistent with liver cirrhosis
·
Absence
of any regularly-prescribed medication
·
Participants
must be age 18 or older
·
Participants
have to be able to lie flat for at least one hour
Updated on
01 Aug 2024.
Study ID: 829482
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting